The Vanguard Group 13D and 13G filings for Pacira BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Pacira BioSciences, Inc. PCRX | The Vanguard Group | 5,098,424 10.980% | 173,229 (+3.52%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX | The Vanguard Group | 4,925,195 10.730% | 259,240 (+5.56%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | The Vanguard Group | 4,665,955 10.470% | 298,689 (+6.84%) | Filing |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | The Vanguard Group | 4,367,266 10.050% | 22,712 (+0.52%) | Filing |
| 2020-02-11 7:24 pm Sale | 2019-12-31 | 13G | Pacira BioSciences, Inc. PCRX | The Vanguard Group | 4,344,554 10.410% | -87,274 (-1.97%) | Filing |